Showing results (311-320 of 331) with videos related to
Sort By:
Pageof 34
Psychosomatic Medicine|March 1, 1997
Posttraumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane AndrewG Ironson, C Wynings, N Schneiderman, et al.Allergy|February 1, 1995
Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E statusM J Miguez-Burbano, G Shor-Posner, M A Fletcher, et al.Clinical Immunology and Immunopathology|May 1, 1990
Leukocyte immunophenotyping by flow cytometry in a multisite study: standardization, quality control, and normal values in the Transfusion Safety Study. The Transfusion Safety Study GroupJ W Parker, B Adelsberg, S P Azen, et al.The Journal of Physiology|May 5, 2025
Pathogenic TNNT1 variants are associated with aberrant thin filament compliance and myofibre hyper-contractilityJenni Laitila, Christopher T A Lewis, Anthony L Hessel, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study GroupD J Lang, A A Kovacs, J A Zaia, et al.Annals of Internal Medicine|November 15, 1990
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donationsE Donegan, M Stuart, J C Niland, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.American Journal of Public Health|February 1, 1990
HIV seropositivity of needles from shooting galleries in south FloridaD D Chitwood, C B McCoy, J A Inciardi, et al.Pageof 34